Infliximab helps with weight gain in Chrones Disease patients

Research carried out at the University of North Carolina in the US, people treated with infliximab who also have chrones disease experience weight gain which so far can not be explained.

It was reported that some crohn's disease patients put on as much as 75 pounds, which is far more than any weight gain that had been witnessed in patients with rheumatoid arthritis and treated with infliximab.

A clinical research fellow at the Universit, Cristal Brown said that chrones patients were often malnourished and that this could help if the fight against the disease. The difficult question to ask is that what if they were to push chrones disease sufferers into obesity and all the associated problems that come with that?

Chrones patients who used Infliximab gained almost five times as much weight as patients with arthritis (4.97 kg versus 1.1 kg) and some people with Crohn's gained as much as 20 to 30 kg. There was no difference in weight gain between patients with luminal versus fistulous disease or by steroid use, baseline body mass index, smoking status, or chrons disease activity. These findings were based on the records on 92 people with Chrons disease and 51 rheumatoid arthritis patients. All of whom were at least 18 years old and who had received three or more infusions of infliximab.

It is thought that many patients with the disease would probably benefit from a small weight gain as the disease often led to some degree of undernourishment, but there is a need for a larger study to determine the cause of this weight gain and the role of leptin in the weight gain.